Medicare Enrolled
Dr. Padmaja Sai, M.D.
Hematology · Palm Coast, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sai? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sai
Dr. Padmaja Sai is a hematology in Palm Coast, FL, with 19 years in practice. Based on federal Medicare data, Dr. Sai performed 420,533 Medicare services across 7,098 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sai received a total of $3,419 from 49 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in FL$ $3,419 industry payments
Medicare Practice Summary
Medicare Utilization ↗420,533
Medicare services
Top 2% in FL for hematology
7,098
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~22,133 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 99,450 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 57,720 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 32,760 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 30,300 | $18 | $51 |
| Iron infusion (Injectafer) | 30,000 | $1 | $3 |
| Oxaliplatin chemotherapy injection | 27,920 | $0 | $12 |
| Epoetin alfa injection (Procrit) for anemia | 25,990 | $6 | $23 |
| Pembrolizumab injection (Keytruda) | 23,000 | $43 | $137 |
| Nivolumab injection (Opdivo) | 16,190 | $23 | $72 |
| Paclitaxel chemotherapy injection | 15,805 | $0 | $2 |
| Dexamethasone injection (steroid) | 6,734 | $0 | $3 |
| Injection, eflapegrastim-xnst, 0.1 mg | 6,600 | $26 | $116 |
| Injection, atezolizumab, 10 mg | 5,280 | $64 | $196 |
| Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 5,122 | $24 | $158 |
| Blood draw (venipuncture) | 4,989 | $8 | $9 |
| Complete blood count (CBC) with differential | 4,832 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,800 | $1 | $28 |
| Office visit, established patient (30-39 min) | 3,075 | $93 | $339 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,940 | $22 | $185 |
| Injection, fulvestrant, 25 mg | 2,100 | $9 | $132 |
| Iron infusion (Monoferric) | 2,000 | $17 | $57 |
| Anti-nausea injection (ondansetron/Zofran) | 1,992 | $0 | $9 |
| Drug injection, under skin or into muscle | 1,920 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 1,086 | $98 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 995 | $21 | $84 |
| Injection, zoledronic acid, 1 mg | 633 | $7 | $69 |
| Injection, carboplatin, 50 mg | 583 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 563 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 556 | $1 | $6 |
| Injection of additional new drug or substance into vein | 526 | $12 | $61 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 498 | $3 | $205 |
| Injection, diphenhydramine hcl, up to 50 mg | 351 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 337 | $21 | $79 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 290 | $55 | $206 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 284 | $17 | $59 |
| Administration of additional new drug or substance into vein, 1 hour or less | 274 | $48 | $178 |
| Prothrombin time test (blood clotting) | 252 | $4 | $15 |
| Office visit, established patient, complex (40-54 min) | 248 | $136 | $474 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 246 | $25 | $89 |
| Injection of drug or substance into vein | 204 | $28 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 187 | $3 | $11 |
| New patient office visit (45-59 min) | 186 | $123 | $453 |
| Automated urinalysis | 176 | $2 | $8 |
| Office visit, established patient (20-29 min) | 175 | $62 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 124 | $15 | $56 |
| Injection, magnesium sulfate, per 500 mg | 112 | $1 | $2 |
| Infusion into a vein for hydration, each additional hour | 107 | $10 | $42 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 103 | $136 | $562 |
| Administration of additional new drug or substance into vein using push technique | 89 | $42 | $170 |
| Infusion, normal saline solution , 1000 cc | 87 | $2 | $7 |
| New patient office visit, complex (60-74 min) | 86 | $168 | $585 |
| Initial hospital admission, high complexity | 82 | $137 | $556 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 77 | $15 | $56 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 72 | $1 | $7 |
| Hospital follow-up visit, moderate complexity | 71 | $63 | $197 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 65 | $4 | $15 |
| Drawing of blood for a medical problem | 64 | $70 | $277 |
| Red blood count, automated test | 61 | $4 | $10 |
| Hospital follow-up visit, high complexity | 55 | $94 | $285 |
| Administration of chemotherapy into vein using push technique | 52 | $75 | $303 |
| Infusion into a vein for hydration, 31-60 minutes | 45 | $25 | $156 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $132 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.8% high complexity
64.7% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,419
Total received (2018-2024)
Avg $488/year across 7 years
Bottom 33% in FL for hematology
49
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,305 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$311
2023$284
2022$615
2021$805
2020$196
2019$782
2018$426
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$346
Seagen Inc.
$332
E.R. Squibb & Sons, L.L.C.
$328
PFIZER INC.
$319
Merck Sharp & Dohme Corporation
$205
Incyte Corporation
$204
Novartis Pharmaceuticals Corporation
$204
Genentech USA, Inc.
$186
Amgen Inc.
$126
Pharmacyclics LLC, An AbbVie Company
$107
Gilead Sciences, Inc.
$89
Exelixis Inc.
$61
GlaxoSmithKline, LLC.
$60
Celgene Corporation
$54
Foundation Medicine, Inc.
$49
Pharmacyclics LLC, an AbbVie Company
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
TG Therapeutics, Inc.
$40
GENZYME CORPORATION
$39
Octapharma USA, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$36
SECURA BIO, INC.
$34
PUMA BIOTECHNOLOGY, INC.
$34
Janssen Pharmaceuticals, Inc
$28
Astellas Pharma US Inc
$28
Taiho Oncology, Inc.
$27
Stemline Therapeutics Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
AstraZeneca Pharmaceuticals LP
$20
ARRAY BIOPHARMA INC
$20
GE HealthCare
$20
ADC Therapeutics America, Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
Array BioPharma Inc.
$18
Kite Pharma, Inc.
$17
Aurobindo Pharma USA, Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
TAIHO ONCOLOGY, INC.
$15
Alexion Pharmaceuticals, Inc.
$14
Blueprint Medicines Corporation
$14
Deciphera Pharmaceuticals Inc.
$14
Secura Bio, Inc.
$13
Dova Pharmaceuticals
$13
AMAG Pharmaceuticals, Inc.
$13
Eisai Inc.
$12
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
MEDIVATION FIELD SOLUTIONS LLC
$12
EMD Serono, Inc.
$12
Veracyte, Inc.
$2
Top 3 companies account for 29.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Avastin · BLENREP · Braftovi · COPIKTRA · COSELA · Cabometyx · DARZALEX · Doptelet · ELIQUIS · ENHERTU · ERLEADA · EVENITY · Erleada · FARYDAK · FERAHEME · FOUNDATIONONE · GAZYVA · Gazyva · Halaven · IMBRUVICA · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · MEKINIST · MONJUVI · Marqibo · NERLYNX · Neulasta · OCREVUS · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · Orserdu · PADCEV · PROMACTA · Polivy · QINLOCK · REBLOZYL · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TECENTRIQ · TUKYSA · Tavalisse · Trodelvy · UKONIQ · Ultomiris · XALKORI · XARELTO · XTANDI · Xospata · YONSA · ZEJULA · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
7
Per 100K population
5.8
County median income
$72,923
Nearest hospital
AdventHealth Palm Coast
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sai is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sai experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sai performed 99,450 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sai receive payments from pharmaceutical companies?
Yes. Dr. Sai received a total of $3,419 from 49 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sai's costs compare to other hematologys in Palm Coast?
Dr. Sai's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Palm Coast
Browse hematologys in Palm Coast ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology